State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.
Virol J. 2011 Jun 22;8:316. doi: 10.1186/1743-422X-8-316.
P24 protein is the major core protein of HIV virus particle and has been suggested as a specific target for antiviral strategies. Recombinant p24 protein with natural antigenic activity would be useful for various studies, such as diagnostic reagents and multi-component HIV vaccine development. The aim of this study was to express and purify the p24 protein in soluble form in E.coli.
According to the sequence of the p24 gene, a pair of primers was designed, and the target sequence of 700 bp was amplified using PCR. The PCR product was cloned into pQE30 vector, generating the recombinant plasmid pQE30-p24. SDS-PAGE analysis showed that the His-tagged recombinant p24 protein was highly expressed in soluble form after induction in E. coli strain BL21. The recombinant protein was purified by nickel affinity chromatography and used to react with HIV infected sera. The results showed that the recombinant p24 protein could specifically react with the HIV infected sera. To study the immunogenicity of this soluble recombinant p24 protein, it was used to immunize mice for the preparation of polyclonal antibody. Subsequent ELISA and Western-Blot analysis demonstrated that the p24 protein had proper immunogenicity in inducing mice to produce HIV p24 specific antibodies.
In this work, we report the high level soluble expression of HIV-1 p24 protein in E. coli. This soluble recombinant p24 protein specifically react with HIV infected sera and elicit HIV p24 specific antibodies in mice, indicating this soluble recombinant p24 protein could be a promising reagent for HIV diagnosis.
P24 蛋白是 HIV 病毒颗粒的主要核心蛋白,已被提议作为抗病毒策略的特定靶标。具有天然抗原活性的重组 p24 蛋白将有助于各种研究,例如诊断试剂和多组分 HIV 疫苗的开发。本研究旨在在大肠杆菌中以可溶形式表达和纯化 p24 蛋白。
根据 p24 基因的序列,设计了一对引物,并使用 PCR 扩增了 700bp 的目标序列。将 PCR 产物克隆到 pQE30 载体中,生成重组质粒 pQE30-p24。SDS-PAGE 分析表明,在大肠杆菌 BL21 菌株中诱导后,带有 His 标签的重组 p24 蛋白以可溶形式高度表达。通过镍亲和层析纯化重组蛋白,并与 HIV 感染血清反应。结果表明,重组 p24 蛋白可特异性与 HIV 感染血清反应。为了研究这种可溶性重组 p24 蛋白的免疫原性,用其免疫小鼠以制备多克隆抗体。随后的 ELISA 和 Western-Blot 分析表明,该 p24 蛋白在诱导小鼠产生 HIV p24 特异性抗体方面具有适当的免疫原性。
在这项工作中,我们报告了 HIV-1 p24 蛋白在大肠杆菌中的高水平可溶性表达。这种可溶性重组 p24 蛋白可特异性与 HIV 感染血清反应,并在小鼠中引发 HIV p24 特异性抗体,表明这种可溶性重组 p24 蛋白可能是 HIV 诊断的有前途的试剂。